window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

healthcare technology

  • Chronic diseases,Patient Centricity,Pharmaceuticals and therapeutics

    Every day is a balancing act: One Mum’s journey raising a daughter with Type 1 diabetes

    This is a disease awareness paid article sponsored by Sanofi. [...]

    November 13, 2025
  • Uncategorised

    Prosper AI raises $5M to expand AI-driven healthcare voice platform

    Artificial intelligence is reshaping the pharmaceutical and healthcare industries, accelerating [...]

    October 3, 2025
  • Artificial Intelligence,Digital Health,Medical devices,Movers & Shakers,Patient Centricity,Regulatory Affairs

    AI tool could spot hospital infections up to 72 hours early

    Sanome’s MEMORI becomes the first UK-developed AI medical device to [...]

    August 20, 2025
  • Artificial Intelligence,Medical devices,Regulatory Affairs

    Artificial intelligence: survey finds medical device industry slow to adopt AI in product operation

    A new survey has found that medical device companies are [...]

    August 20, 2025
  • Medical devices,Movers & Shakers,Technology and platforms

    ASP launches instant read steam system for near-immediate sterility assurance

    Advanced Sterilization Products (ASP) has introduced a new steam biological [...]

    August 7, 2025
  • Artificial Intelligence,Regulatory Affairs,Technology and platforms

    FDA launches AI tool Elsa to boost internal efficiency and accelerate reviews

    The US Food and Drug Administration (FDA) has unveiled Elsa, [...]

    June 8, 2025
  • Clinical Trials,Partnerships & Funding,Patient Centricity,Regulatory Affairs,Technology and platforms

    Cybin teams up with Osmind to advance Phase 3 psychedelic therapy for depression

    As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]

    June 2, 2025
  • Cell & Gene Therapy,Technology and platforms

    Title21 appoints expert committee to support cell and gene therapy platform development

    May 7, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top